Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer
Wenbin Zhou, Yayuan Zhang, Caineng Zhong, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 3687-3696
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Multipronged regulation of autophagy and apoptosis: emerging role of TRIM proteins
Nuzhat Ahsan, Mohd Shariq, Avadhesha Surolia, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 20
Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects
Sara Tenti, Pierpaolo Correale, Sara Cheleschi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5625-5625
Open Access | Times Cited: 80
TRIM21 – A potential novel therapeutic target in cancer
Munther Alomari
Pharmacological Research (2021) Vol. 165, pp. 105443-105443
Closed Access | Times Cited: 70
TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease
Esther L. Jones, Stephen M. Laidlaw, Lynn B. Dustin
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis
Xintian Chen, Zhongwei Li, Hongmei Yong, et al.
Cancer Letters (2021) Vol. 508, pp. 115-126
Closed Access | Times Cited: 58
SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma
Wei Wu, Zhenghao Zhang, Doudou Jing, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 42
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer
Juan Liu, Cen Zhang, Dandan Xu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 31
TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma.
Zhipeng Zhao, Yuqi Wang, Dapeng Yun, et al.
PubMed (2020) Vol. 10, Iss. 1, pp. 114-130
Closed Access | Times Cited: 53
The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
Michael A. Mandell, Bhaskar Saha, Todd A. Thompson
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 50
SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21
Wenzhe Si, Jiansuo Zhou, Yang Zhao, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 47
TRIM21 Is Decreased in Colitis-associated Cancer and Negatively Regulates Epithelial Carcinogenesis
Guangxi Zhou, Huili Wu, Jian Lin, et al.
Inflammatory Bowel Diseases (2020) Vol. 27, Iss. 4, pp. 458-468
Open Access | Times Cited: 47
TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy
Huan‐Tian Zhang, Qingzhong Zeng, Baomeng Wu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Targeting mutant p53 stabilization for cancer therapy
Jiajian Wang, Wenjun Liu, Lanqing Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation
Alice Fletcher, Dean Clift, Emma de Vries, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
TRIM21/USP15 balances ACSL4 stability and the imatinib resistance of gastrointestinal stromal tumors
Zhiwei Cui, Haoyu Sun, Zhishuang Gao, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 4, pp. 526-541
Closed Access | Times Cited: 5
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms
Ali Mohammadi, Mohammad Sadegh Pour Abbasi, Samaneh Khorrami, et al.
Clinical & Translational Oncology (2021) Vol. 24, Iss. 3, pp. 460-470
Closed Access | Times Cited: 28
EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail
Jiani Yang, Yuanyu Liao, Bojun Wang, et al.
Cancer Letters (2023) Vol. 577, pp. 216427-216427
Open Access | Times Cited: 11
Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation
Ghania Hounana Kara-Ali, Luis Cano, Sarah Dion, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 11, pp. 1999-2013
Open Access | Times Cited: 4
The Role of Ubiquitin-Proteasome System (UPS) in Asthma Pathology
Shaoping Deng, Le Ding, Yisong Qian, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 307-330
Open Access
NKAPL suppresses NSCLC progression by enhancing the protein stability of TRIM21 and further inhibiting the NF-κB signaling pathway
Chunhong Li, Qiang Wang, Fengsheng Dai, et al.
Genes & Diseases (2025), pp. 101598-101598
Open Access
Designed peptide binders and nanobodies as PROTAC starting points for targeted degradation of PCNA and BCL6
Shuai Zhao, Jingwen Luo, Pingping Xu, et al.
International Journal of Biological Macromolecules (2025), pp. 142667-142667
Closed Access
An Investigation of TRIM36 Expression in Breast Cancer
A F Celik, Sevim Çelik, Güldeniz Karadeniz Çakmak, et al.
Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi (2025) Vol. 12, Iss. 1, pp. 21-26
Closed Access
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21
Minhua Deng, Wensu Wei, Jin‐Ling Duan, et al.
Cancer Science (2021) Vol. 112, Iss. 5, pp. 1758-1771
Open Access | Times Cited: 25
TRIM21 improves apatinib treatment in gastric cancer through suppressing EZH1 stability
Ping Mei, Shumin Wang, Yarong Guo, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 586, pp. 177-184
Closed Access | Times Cited: 25
The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism
Chueh-Hsuan Hsu, Yung‐Luen Yu
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top